Professor Aniebiet Inyang Ntui is a multi-faceted individual whose expertise spans the worlds of library and information science, environmental advocacy, and – perhaps surprisingly – the automotive ...
HOWL reported interim data in November from its phase 1/1b trial of WTX-124 in solid tumors. There are signs of antitumor activity at the 12 mg dose of WTX-124, with two unconfirmed partial responses ...